儿童脓毒症凝血病评分与平均血小板体积/血小板计数比值在脓毒症患儿中的应用价值
该回顾性队列纳入聊城市第二人民医院PICU 2020年1月至2023年12月收治的112例脓毒症患儿为脓毒症组,同期小儿外科腹股沟疝择期手术的50例无脓毒症患儿为对照组;脓毒症组按小儿危重病例评分(PCIS)≤80分(危重组46例)与>80分(非危重组66例)分组。结果显示脓毒症组pSIC评分、PT、INR、APTT、FIB、MPV、MPV/PLT比值均高于对照组(均P<0.01),PLT略低(P>0.05);危重组pSIC评分、PT、INR、APTT、MPV、MPV/PLT比值均高于非危重组(均P<0.05),PLT显著低于非危重组(P<0.01),FIB略低(P>0.05)。多因素Logistic回归示pSIC评分与MPV/PLT比值是儿童脓毒症及重症脓毒症的独立危险因素;ROC曲线示两者联合诊断脓毒症AUC 0.815、判定重症脓毒症AUC 0.872。
要点
- 脓毒症组pSIC评分0.93±0.10 vs 对照组0.06±0.03,MPV/PLT比值0.037±0.003 vs 0.022±0.001(均P<0.01)。
- 危重组pSIC评分1.74±0.17 vs 非危重组0.36±0.07,MPV/PLT比值0.051±0.006 vs 0.027±0.001(均P<0.05)。
- 多因素Logistic回归:pSIC评分诊断儿童脓毒症OR 14.117(95%CI 4.190-47.555),MPV/PLT比值OR 1.128(95%CI 1.059-1.202),均P<0.01。
- 判定重症脓毒症:pSIC评分OR 8.142(95%CI 3.672-18.050),MPV/PLT比值OR 1.068(95%CI 1.028-1.109),均P<0.01。
- ROC曲线:pSIC评分诊断脓毒症AUC 0.754(95%CI 0.700-0.808),MPV/PLT比值AUC 0.720(95%CI 0.643-0.798);判定重症脓毒症AUC分别为0.849(95%CI 0.778-0.919)与0.731(95%CI 0.632-0.830);
适用人群与场景
- 脓毒症组:2020年1月至2023年12月聊城市第二人民医院PICU收治的112例脓毒症患儿。
- 对照组:同期该院小儿外科因腹股沟疝择期手术的50例无脓毒症患儿。
- 脓毒症患儿按小儿危重病例评分(PCIS)分组:≤80分为危重组(46例),>80分为非危重组(66例)。
诊断标准与关键阈值
- 小儿危重病例评分(PCIS)≤80分定义为危重病例,>80分为非危重病例。
研究设计与关键结果
- 研究类型:回顾性队列研究;样本量:112例脓毒症患儿与50例无脓毒症对照患儿。
- 脓毒症组vs对照组:pSIC评分0.93±0.10 vs 0.06±0.03,PT(s)14.76±0.38 vs 12.23±0.15,INR 1.26±0.03 vs 1.06±0.01,APTT(s)40.08±0.94 vs 32.47±0.54,FIB(g/L)3.51±0.11 vs 2.31±0.06,MPV(fL)8.86±0.14 vs 7.62±0.11,MPV/PLT比值0.037±0.003 vs 0.022±0.001,均P<0.01;PLT(×10^9/L)306.00±11.01 vs 345.90±10.57,P>0.05。
- 危重组vs非危重组:pSIC评分1.74±0.17 vs 0.36±0.07,PT(s)16.55±0.80 vs 13.52±0.23,INR 1.39±0.07 vs 1.17±0.02,APTT(s)43.83±1.72 vs 37.77±0.95,MPV(fL)9.31±0.23 vs 8.55±0.16,MPV/PLT比值0.051±0.006 vs 0.027±0.001,均P<0.05;PLT(×10^9/L)260.50±18.89 vs 337.70±11.90,P<0.01;FIB(g/L)3.28±0.19 vs 3.67±0.14,P>0.05。
- 相关性分析:儿童脓毒症中pSIC评分与MPV/PLT比值、PT、APTT、INR呈显著正相关(r值分别为0.583、0.571、0.296、0.518,均P<0.01);MPV/PLT比值与PT、APTT、INR呈显著正相关(r值分别为0.300、0.203、0.307,均P<0.05)。
- 多因素Logistic回归:儿童脓毒症中pSIC评分OR 14.117(95%CI 4.190-47.555),MPV/PLT比值OR 1.128(95%CI 1.059-1.202),均P<0.01;重症脓毒症中pSIC评分OR 8.142(95%CI 3.672-18.050),MPV/PLT比值OR 1.068(95%CI 1.028-1.109),均P<0.01。
- ROC曲线:诊断儿童脓毒症pSIC评分AUC 0.754(95%CI 0.700-0.808),MPV/PLT比值AUC 0.720(95%CI 0.643-0.798),两者联合AUC 0.815(95%CI 0.751-0.879);判定重症脓毒症pSIC评分AUC 0.849(95%CI 0.778-0.919),MPV/PLT比值AUC 0.731(95%CI 0.632-0.830),两者联合AUC 0.872(95%CI 0.806-0.938)。
证据类型、等级与局限
- 证据类型:回顾性队列研究。
- 局限:原文未报告局限性。
对床旁实践的改变
- 作者认为pSIC评分与MPV/PLT比值在儿童脓毒症诊断及重症脓毒症判定中具有潜在应用价值,两者联合应用价值更高。
提炼说明
- 本条依据论文摘要整理;摘要未涉及「处置流程与药物剂量」「红旗征与不能漏的情况」「指南或共识出处」,故未列出这些栏目;全文请点「阅读原文」。
英文原文(摘要)· 点击展开
OBJECTIVE: To investigate the application value of pediatric sepsis-induced coagulation (pSIC) score and mean platelet volume/platelet count (MPV/PLT) ratio in the diagnosis of pediatric sepsis and the determination of critical pediatric sepsis.
METHODS: A retrospective cohort study was conducted, selecting 112 children with sepsis (sepsis group) admitted to pediatric intensive care unit (PICU) of Liaocheng Second People's Hospital from January 2020 to December 2023 as the study objects, and 50 children without sepsis admitted to the pediatric surgery department of our hospital during the same period for elective surgery due to inguinal hernia as the control (control group). The children with sepsis were divided into two groups according to the pediatric critical case score (PCIS). The children with PCIS score of ≤ 80 were classified as critically ill group, and those with PCIS score of > 80 was classified as non-critically ill group. pSIC score, coagulation indicators [prothrombin time (PT), international normalized ratio (INR), activated partial thromboplastin time (APTT), and fibrinogen (FIB)], and platelet related indicators (PLT, MPV, and MPV/PLT ratio) were collected. Pearson correlation method was used to analyze the correlation between pSIC score and MPV/PLT ratio as well as their correlation with coagulation indicators. Multivariate Logistic regression analysis was used to screen the independent risk factors for pediatric sepsis and critical pediatric sepsis. Receiver operator characteristic curve (ROC curve) was drawn to evaluate the application value of the above independent risk factors on the diagnosis of pediatric sepsis and the determination of critical pediatric sepsis.
RESULTS: 112 children with sepsis and 50 children without sepsis were enrolled in the final analysis. pSIC score, PT, INR, APTT, FIB, MPV, and MPV/PLT ratio in the sepsis group were significantly higher than those in the control group [pSIC score: 0.93±0.10 vs. 0.06±0.03, PT (s): 14.76±0.38 vs. 12.23±0.15, INR: 1.26±0.03 vs. 1.06±0.01, APTT (s): 40.08±0.94 vs. 32.47±0.54, FIB (g/L): 3.51±0.11 vs. 2.31±0.06, MPV (fL): 8.86±0.14 vs. 7.62±0.11, MPV/PLT ratio: 0.037±0.003 vs. 0.022±0.001, all P < 0.01], and PLT was slightly lower than that in the control group (×109/L: 306.00±11.01 vs. 345.90±10.57, P > 0.05). Among 112 children with sepsis, 46 were critically ill and 66 were non-critically ill. pSIC score, PT, INR, APTT, MPV, and MPV/PLT ratio in the critically ill group were significantly higher than those in the non-critically ill group [pSIC score: 1.74±0.17 vs. 0.36±0.07, PT (s): 16.55±0.80 vs. 13.52±0.23, INR: 1.39±0.07 vs. 1.17±0.02, APTT (s): 43.83±1.72 vs. 37.77±0.95, MPV (fL): 9.31±0.23 vs. 8.55±0.16, MPV/PLT ratio: 0.051±0.006 vs. 0.027±0.001, all P < 0.05], PLT was significantly lower than that in the non-critically ill group (×109/L: 260.50±18.89 vs. 337.70±11.90, P < 0.01), and FIB was slightly lower than that in the non-critically ill group (g/L: 3.28±0.19 vs. 3.67±0.14, P > 0.05). Correlation analysis showed that pSIC score was significantly positively correlated with MPV/PLT ratio and coagulation indicators including PT, APTT and INR in pediatric sepsis (r value was 0.583, 0.571, 0.296 and 0.518, respectively, all P < 0.01), and MPV/PLT ratio was also significantly positively correlated with PT, APTT and INR (r value was 0.300, 0.203 and 0.307, respectively, all P < 0.05). Multivariate Logistic regression analysis showed that pSIC score and MPV/PLT ratio were independent risk factors for pediatric sepsis and critical pediatric sepsis [pediatric sepsis: odds ratio (OR) and 95% confidence interval (95%CI) for pSIC score was 14.117 (4.190-47.555), and the OR value and 95%CI for MPV/PLT ratio was 1.128 (1.059-1.202), both P < 0.01; critical pediatric sepsis: the OR value and 95%CI for pSIC score was 8.142 (3.672-18.050), and the OR value and 95%CI for MPV/PLT ratio was 1.068 (1.028-1.109), all P < 0.01]. ROC curve analysis showed that pSIC score and MPV/PLT ratio had certain application value in the diagnosis of pediatric sepsis [area under the ROC curve (AUC) and 95%CI was 0.754 (0.700-0.808) and 0.720 (0.643-0.798), respectively] and the determination of critical pediatric sepsis [AUC and 95%CI was 0.849 (0.778-0.919) and 0.731 (0.632-0.830)], and the combined AUC of the two indictors was 0.815 (95%CI was 0.751-0.879) and 0.872 (95%CI was 0.806-0.938), respectively.
CONCLUSIONS: pSIC score and MPV/PLT ratio have potential application value in the diagnosis of pediatric sepsis and the determination of critical pediatric sepsis, and the combined application of both is more valuable.
参考来源
- Han J, Zhang X, Wang Z, et al. [Application value of pediatric sepsis-induced coagulopathy score and mean platelet volume/platelet count ratio in children with sepsis]. Zhonghua Wei Zhong Bing Ji Jiu Yi Xue. 2025. PMID: 40814709. doi:10.3760/cma.j.cn121430-20240629-00554
供执业医师抢救与诊疗参考,不替代临床判断;剂量请结合体重、肝肾功能和本院药品规格复核,以指南原文为准。